Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in J Autoimmun Retrieve available abstracts of 197 articles: HTML format

Single Articles

October 2026
1. CARNEIRO P, Vicente MM, Alves I, Azevedo CM, et al
   Treg-associated oligomannose N-glycans trigger immune dysregulation in myasthenia gravis.
   J Autoimmun. 2026;165:103643.
   PubMed     Abstract available
   
   
   
2. RUGGE M, Genta RM, Graham DY
   Autoimmune gastritides: A critical review.
   J Autoimmun. 2026;164:103642.
   PubMed     Abstract available
   
   
   
3. VELLAS D, Berges A, De Rycke Y, Pinto S, et al
   Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data.
   J Autoimmun. 2026;164:103639.
   PubMed     Abstract available
   
   
   September 2026
4. JIANG Q, Zhu G, Si W, Ma X, et al
   Single-cell transcriptomics reveal tissue-specific neutrophil heterogeneity and functional reprogramming in autoimmunity.
   J Autoimmun. 2026;164:103637.
   PubMed     Abstract available
   
   
   
5. FILIPOVIC M, Afonso M, Argyriou A, Circiumaru A, et al
   Increased CCL22 production in early rheumatoid arthritis development with potential impact on mucosal autoimmunity, joint inflammation and T cell recruitment to LAMP3+ dendritic cells.
   J Autoimmun. 2026;164:103633.
   PubMed     Abstract available
   
   
   
6. AVENATTI MC, Elizagaray ML, Purba MC, Barrachina F, et al
   Intercalated cells contribute to the immune responses in renal autoimmune disease.
   J Autoimmun. 2026;164:103619.
   PubMed     Abstract available
   
   
   
7. VAN OOSTVEEN WM, Alzahrani AM, Neppelenbroek S, Levarht EWN, et al
   Autoantibodies in systemic sclerosis display a proinflammatory Fc glycosylation signature independent of systemic inflammation.
   J Autoimmun. 2026;164:103623.
   PubMed     Abstract available
   
   
   
8. LARSEN ML, Demir F, Langkilde HZ, Linge P, et al
   Disease-activity-linked complement-coagulation interactions and persistent platelet activation in treatment-naive systemic lupus erythematosus.
   J Autoimmun. 2026;164:103615.
   PubMed     Abstract available
   
   
   
9. GUO H, Liu W, Xiang W, Zeng L, et al
   PTX3 in rheumatic and autoimmune diseases: Pathogenesis, biomarker potential, and therapeutic implications.
   J Autoimmun. 2026;164:103620.
   PubMed     Abstract available
   
   
   
10. KARINO K, Oba S, Imai R, Kono M, et al
    HIF-1alpha regulates ADAM9 expression in Th17 cells during autoimmune disease.
    J Autoimmun. 2026;164:103621.
    PubMed     Abstract available
    
    
    
11. GANDOLFO S, Parodis I, Mauro D, Riccio F, et al
    Difficult-to-treat systemic lupus erythematosus: from refractory disease to a multidimensional clinical trajectory.
    J Autoimmun. 2026;164:103617.
    PubMed     Abstract available
    
    
    
12. IORIO L, Davanzo F, Lorenzoni G, Gasparini D, et al
    Rheumatoid factor is associated with systemic relapse in eosinophilic granulomatosis with polyangiitis.
    J Autoimmun. 2026;163:103613.
    PubMed     Abstract available
    
    
    August 2026
13. CHEN Z, Yan S, Deng C, Wang W, et al
    Unveiling the role of abnormal copper metabolism in systemic lupus erythematosus.
    J Autoimmun. 2026;163:103614.
    PubMed     Abstract available
    
    
    
14. LOU H, Zhang M, Zhang B, Lu Q, et al
    Multimodal computational framework resolves B cell maturation in autoimmunity and ageing.
    J Autoimmun. 2026;163:103609.
    PubMed     Abstract available
    
    
    
15. VERGOOSSEN DLE, Verpalen R, Jensen SM, Fonhof S, et al
    MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.
    J Autoimmun. 2026;162:103593.
    PubMed     Abstract available
    
    
    
16. HERTWIG M, Oehrl S, Dobel T, Zhang H, et al
    A gradient of immune complexes induces directional migration and a lupus-associated transcriptional program in Slan(+) non-classical monocytes.
    J Autoimmun. 2026;162:103579.
    PubMed     Abstract available
    
    
    July 2026
17. JANSSEN LMF, de Ocampo C, Kono DH, Hoet PHM, et al
    Crystalline silica exposure of genetically diverse mice exacerbates subclinical autoimmunity into systemic autoimmune disease phenotypes including inflammatory arthritis in female mice.
    J Autoimmun. 2026;163:103599.
    PubMed     Abstract available
    
    
    
18. GONZALEZ-MUNOZ C, Baeten P, Hermans D, Hoeks C, et al
    Itolizumab targets the CD6-ALCAM axis to limit T-cell responses and brain barrier diapedesis in multiple sclerosis.
    J Autoimmun. 2026;163:103598.
    PubMed     Abstract available
    
    
    
19. GOMES GS, Cagle C, Li W, Visioli F, et al
    Immunomodulatory effects of tacrolimus-loaded lipid-core nanocapsules in autoimmune hepatitis.
    J Autoimmun. 2026;163:103597.
    PubMed     Abstract available
    
    
    
20. ADAMSEN ML, Rasmussen IE, Printz Lyngbaek MP, Louise L Petersen M, et al
    Randomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus.
    J Autoimmun. 2026;162:103595.
    PubMed     Abstract available
    
    
    
21. OH TK, Song IA
    Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children.
    J Autoimmun. 2026;162:103596.
    PubMed     Abstract available
    
    
    June 2026
22. SUZUKI S, Iida M, Wakahara T, Shiko Y, et al
    Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.
    J Autoimmun. 2026;162:103588.
    PubMed     Abstract available
    
    
    May 2026
23. LI R, Li X, Zhu X, Liu S, et al
    Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.
    J Autoimmun. 2026;161:103578.
    PubMed     Abstract available
    
    
    
24. SORGJERD EP, Hals IK, Lonnum BE, Edstorp J, et al
    Impacts of HLA-DR3DQ2 and HLA-DR4DQ8 haplotypes singly and combined on autoimmunity, phenotype and comorbidity in patients with Latent Autoimmune Diabetes in the adult. Results from the HUNT and ESTRID studies.
    J Autoimmun. 2026;161:103576.
    PubMed     Abstract available
    
    
    
25. OREFICE NS, Meijns NRC, Di Martino E, Schepers M, et al
    PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis.
    J Autoimmun. 2026;161:103577.
    PubMed     Abstract available
    
    
    
26. SAYADI A, Eloranta ML, Oparina N, Wallgren M, et al
    Single-cell RNA-seq reveals a persistent interferon signature in immune cells from systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial treatment.
    J Autoimmun. 2026;161:103575.
    PubMed     Abstract available
    
    
    
27. BENONNIER N, Robert M, Sousa Alves A, Catella J, et al
    Machine learning-based cardiovascular risk prediction in systemic lupus erythematosus: development and internal validation of a prognostic model.
    J Autoimmun. 2026;161:103561.
    PubMed     Abstract available
    
    
    
28. LI Z, Li H, Tian B, Liu H, et al
    Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study.
    J Autoimmun. 2026;160:103560.
    PubMed     Abstract available
    
    
    April 2026
29. GAN Y, Liang W, Liu C, Yalavarthi S, et al
    Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.
    J Autoimmun. 2026;161:103563.
    PubMed     Abstract available
    
    
    
30. MORONI G, Uzzo M, Calatroni M, Conte E, et al
    Chronic kidney disease trajectories in lupus nephritis: Is progression unavoidable?
    J Autoimmun. 2026;161:103558.
    PubMed     Abstract available
    
    
    
31. MAKUS B, Schulze D, Lehnerer S, Gerischer L, et al
    Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot study.
    J Autoimmun. 2026;160:103562.
    PubMed     Abstract available
    
    
    
32. HAN AR, Alzahrani M, Luu TV, Dambaeva S, et al
    Autoimmune modulation of immune-endocrine-metabolic regulation of ovarian reserve: A cohort study of 803 women.
    J Autoimmun. 2026;160:103552.
    PubMed     Abstract available
    
    
    March 2026
33. CUI Z, Ooi JD, Ting YT
    TCR recognition of peptide-HLA class II complexes in autoimmunity: Structural insights for therapeutic targeting.
    J Autoimmun. 2026;160:103549.
    PubMed     Abstract available
    
    
    
34. HARVEY GR, Ashur I, Bossuyt X, Bluethner M, et al
    Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.
    J Autoimmun. 2026;160:103548.
    PubMed     Abstract available
    
    
    
35. CHENG V, Sayre EC, Amiri N, Cragg JJ, et al
    Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study.
    J Autoimmun. 2026;159:103538.
    PubMed     Abstract available
    
    
    February 2026
36. VAN GOMPEL E, Galesic M, Delaroque N, Kern K, et al
    Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.
    J Autoimmun. 2026;159:103536.
    PubMed     Abstract available
    
    
    
37. VERONI C, Carbone F, Ricci D, Proietti S, et al
    Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy.
    J Autoimmun. 2026;159:103533.
    PubMed     Abstract available
    
    
    
38. VAN PUIJFELIK F, Kuiper KL, Rip J, Smolders J, et al
    What's in a name? - juxtaposing T follicular, peripheral and resident helper cells in B cell-driven autoimmune diseases.
    J Autoimmun. 2026;159:103535.
    PubMed     Abstract available
    
    
    January 2026
39. BERETTA L, Chan CWS, Moysidou GS, Nothling DM, et al
    Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response.
    J Autoimmun. 2026;159:103525.
    PubMed     Abstract available
    
    
    
40. DESALEGN D, Fischer S, Bedada Y, Freuer D, et al
    Autoimmunity to mental health: Risk of depression in type 1 diabetes and celiac disease patients - A systematic review, meta-analysis, and bias assessment.
    J Autoimmun. 2026;158:103524.
    PubMed     Abstract available
    
    
    
41. LEIJDING C, Gastaldello S, Schiffer T, Kaewin S, et al
    Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.
    J Autoimmun. 2026;158:103522.
    PubMed     Abstract available
    
    
    December 2025
42. ROCCATELLO D, Barinotti A, Radin M, Cecchi I, et al
    Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study.
    J Autoimmun. 2025;158:103520.
    PubMed     Abstract available
    
    
    
43. TALAMINI L, Verdot C, Shoenfeld Y, Muller S, et al
    Pathophysiological effects of long COVID-19 (auto)antibodies on fertility.
    J Autoimmun. 2025;158:103518.
    PubMed     Abstract available
    
    
    
44. TIAN T, Rao L, Wei M, Du J, et al
    Circadian clock genes: Potential therapeutic targets for autoimmune diseases.
    J Autoimmun. 2025;158:103516.
    PubMed     Abstract available
    
    
    
45. SOUSA CDF, Terroba-Navajas P, Tzartos J, Oreskovic ID, et al
    Humoral correlates of clinical response to thymectomy in myasthenia gravis.
    J Autoimmun. 2025;158:103517.
    PubMed     Abstract available
    
    
    
46. NIELSEN HB, Gupta N, Andersen AJ, Dreyer LW, et al
    Physical work demands and risk of rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus. A Danish longitudinal cohort study.
    J Autoimmun. 2025;158:103514.
    PubMed     Abstract available
    
    
    November 2025
47. FRITZLER MJ, Muro Y, Klotz W, Herold M, et al
    Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern.
    J Autoimmun. 2025;158:103503.
    PubMed     Abstract available
    
    
    
48. SAXENA D, Walter K, Amona E, Kong M, et al
    Prior murine neurotropic coronavirus infection ameliorates experimental autoimmune encephalitis.
    J Autoimmun. 2025;158:103504.
    PubMed     Abstract available
    
    
    
49. HASSLER S, Aste J, Berenbaum F, Rosenzwajg M, et al
    Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis.
    J Autoimmun. 2025;157:103502.
    PubMed     Abstract available
    
    
    
50. XI W, Feng Y, Shi W, Li J, et al
    Association between age groups and relapse of type 1 autoimmune pancreatitis: a large-scale retrospective cohort study.
    J Autoimmun. 2025;157:103499.
    PubMed     Abstract available
    
    
    October 2025
51. AN X, Huang X
    Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases.
    J Autoimmun. 2025;157:103495.
    PubMed     Abstract available
    
    
    
52. WANG Y, Yang S, Yu Y, Xia P, et al
    Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study.
    J Autoimmun. 2025;157:103489.
    PubMed     Abstract available
    
    
    September 2025
53. FUKUI S, Michitsuji T, Endo Y, Nishino A, et al
    Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis.
    J Autoimmun. 2025;157:103490.
    PubMed     Abstract available
    
    
    
54. LIU X, Wang C, Guan X
    Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus.
    J Autoimmun. 2025;157:103488.
    PubMed     Abstract available
    
    
    
55. STASCHEIT F, Schulze D, Lehnerer S, Gerischer L, et al
    Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy-A pilot study.
    J Autoimmun. 2025;157:103476.
    PubMed     Abstract available
    
    
    
56. KELLY S, Singh M, Russell A, Jackson KJL, et al
    Lymphoma driver mutations at the root of somatic evolution of nerve-damaging autoantibodies in myelin associated glycoprotein neuropathy.
    J Autoimmun. 2025;157:103474.
    PubMed     Abstract available
    
    
    
57. SONG Y, Zhou B, Long J, Peng Y, et al
    Targeted protein degradation in autoimmune diseases: from mechanisms to therapeutic breakthroughs.
    J Autoimmun. 2025;156:103475.
    PubMed     Abstract available
    
    
    
58. MALHAM M, Sejling C, Davies M, Wewer V, et al
    How early-life adversity affects the risk of pediatric-onset immune-mediated inflammatory disease.
    J Autoimmun. 2025;156:103457.
    PubMed     Abstract available
    
    
    August 2025
59. ZHU M, Li X, Zhao K, Huang Z, et al
    Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases.
    J Autoimmun. 2025;156:103472.
    PubMed     Abstract available
    
    
    
60. YI X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al
    Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection.
    J Autoimmun. 2025;156:103469.
    PubMed     Abstract available
    
    
    
61. HEBBANDI NANJUNDAPPA R, Kolla HB, Edgar A, Leung PS, et al
    Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis.
    J Autoimmun. 2025;156:103473.
    PubMed     Abstract available
    
    
    
62. WANG Y, Wang S, Liu W, Gu H, et al
    Corrigendum to "Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice" [J. Autoimmun. 145 (2024) 103205].
    J Autoimmun. 2025 Aug 2:103470. doi: 10.1016/j.jaut.2025.103470.
    PubMed    
    
    
    July 2025
63. SENDO S, Vela AJ, Ro M, Thiruppathy D, et al
    Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice.
    J Autoimmun. 2025;156:103452.
    PubMed     Abstract available
    
    
    
64. OTT R, Singh T, Schutte-Borkovec K, Scholz M, et al
    Epigenetic differences at immune and type 1 diabetes susceptibility genes in blood from young children after COVID-19 infection.
    J Autoimmun. 2025;156:103468.
    PubMed     Abstract available
    
    
    June 2025
65. PIREDDU MP, Rizzo G, Congiu F, Chessa E, et al
    Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus.
    J Autoimmun. 2025;155:103455.
    PubMed     Abstract available
    
    
    
66. VAN DEN BEUKEL MD, Zhang L, van der Meulen S, Borggreven NV, et al
    Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.
    J Autoimmun. 2025;155:103444.
    PubMed     Abstract available
    
    
    
67. LEE YJ, Fang YW, Chen MT, Liou HH, et al
    Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study.
    J Autoimmun. 2025;155:103453.
    PubMed     Abstract available
    
    
    
68. RENAUDINEAU Y, Sposito F, Natoli V, Charras A, et al
    Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus.
    J Autoimmun. 2025;155:103451.
    PubMed     Abstract available
    
    
    
69. SAKSAGER AB, Hede FD, Barra C
    Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases.
    J Autoimmun. 2025;155:103443.
    PubMed     Abstract available
    
    
    May 2025
70. HOCAOGLU M, Sawalha AH
    Integrated analysis of polygenic and environmental risk scores for late-onset systemic lupus erythematosus.
    J Autoimmun. 2025;154:103441.
    PubMed     Abstract available
    
    
    
71. VAN DOOREN HJ, Atisha-Fregoso Y, Dorjee AL, Huizinga TWJ, et al
    Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus.
    J Autoimmun. 2025;154:103438.
    PubMed     Abstract available
    
    
    
72. LEE S, Jo AR, Kim Y, Lee W, et al
    Association between occupational and environmental dust exposure and autoimmune diseases: A systematic review and meta-analysis.
    J Autoimmun. 2025;154:103440.
    PubMed     Abstract available
    
    
    
73. MAZZUCATO-PUCHNER A, Ramspeck H, Ritschl V, Stamm T, et al
    Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study.
    J Autoimmun. 2025;154:103439.
    PubMed     Abstract available
    
    
    
74. WANG P, Yuksel M, Gabeta S, Graham J, et al
    HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.
    J Autoimmun. 2025;154:103436.
    PubMed     Abstract available
    
    
    
75. SU QY, Zheng XX, Han XT, Li Q, et al
    The role of age-associated B cells in systemic lupus erythematosus.
    J Autoimmun. 2025;154:103433.
    PubMed     Abstract available
    
    
    
76. HU H, Peng Y, Wang CC, Chen J, et al
    Neutrophil extracellular traps induce trophoblasts pyroptosis via enhancing NLRP3 lactylation in SLE pregnancies.
    J Autoimmun. 2025;153:103411.
    PubMed     Abstract available
    
    
    
77. KNOX JJ, Scholz JL, Futeran H, Cataliotti S, et al
    T-bet(+)CD11c(+) age-associated B cells resist BLyS- and CD20-targeted ablation in murine lupus models.
    J Autoimmun. 2025;153:103410.
    PubMed     Abstract available
    
    
    
78. MATTIOLI I, Urban ML, Padoan R, Mohammad AJ, et al
    Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.
    J Autoimmun. 2025;153:103398.
    PubMed     Abstract available
    
    
    April 2025
79. WANG L, Christodoulou MI, Jin Z, Ma Y, et al
    Human regulatory B cells suppress autoimmune disease primarily via interleukin-37.
    J Autoimmun. 2025;153:103415.
    PubMed     Abstract available
    
    
    
80. CHEVALIER K, Thoreau B, Michel M, Godeau B, et al
    Treatment of mixed connective tissue disease: A multicenter retrospective study.
    J Autoimmun. 2025;153:103420.
    PubMed     Abstract available
    
    
    
81. SHIRAHAMA S, Okunuki Y, Lee MY, Karg MM, et al
    Preventing the antigen-presenting function of retinal microglia blocks autoimmune neuroinflammation by dendritic cell-primed CD4(+) T cells.
    J Autoimmun. 2025;153:103417.
    PubMed     Abstract available
    
    
    
82. YANG Y, Liu W, Zhang Z, Zhang Y, et al
    Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases.
    J Autoimmun. 2025;153:103414.
    PubMed     Abstract available
    
    
    March 2025
83. HE J, Guo Y, Chen J, Xu J, et al
    Exploring the correlation between UVB sensitivity and SLE activity: Insights into UVB-driven pathogenesis in lupus erythematosus.
    J Autoimmun. 2025;153:103393.
    PubMed     Abstract available
    
    
    
84. XU H, Zhan M, Wu Z, Chen J, et al
    Aberrant expansion of CD177(+) neutrophils promotes endothelial dysfunction in systemic lupus erythematosus via neutrophil extracellular traps.
    J Autoimmun. 2025;152:103399.
    PubMed     Abstract available
    
    
    
85. ZHANG S, Wen Q, Su S, Wang Y, et al
    Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis.
    J Autoimmun. 2025;152:103395.
    PubMed     Abstract available
    
    
    
86. RAUBER S, Schulte-Mecklenbeck A, Sarink K, Golombeck KS, et al
    Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis.
    J Autoimmun. 2025;152:103396.
    PubMed     Abstract available
    
    
    
87. NOELKER C, Seitz F, Sturn A, Neff F, et al
    Autoantibodies against alpha-synuclein inhibit its aggregation and cytotoxicity.
    J Autoimmun. 2025;152:103390.
    PubMed     Abstract available
    
    
    
88. SU C, Cong A, Wu H, Zhou Z, et al
    Glomerular CD68(+) macrophages infiltration at initial biopsy predicts response to standard immunosuppression in proliferative lupus nephritis: CD68(+) Mo predicts LN treatment response.
    J Autoimmun. 2025;152:103392.
    PubMed     Abstract available
    
    
    
89. ATTRILL MH, Shinko D, Viveiros TM, Milighetti M, et al
    Treg fitness signatures as a biomarker for disease activity in Juvenile Idiopathic Arthritis.
    J Autoimmun. 2025;152:103379.
    PubMed     Abstract available
    
    
    February 2025
90. WANG R, Lin Q, Sheng L, Zhang Y, et al
    Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis.
    J Autoimmun. 2025;152:103387.
    PubMed     Abstract available
    
    
    
91. WEBER A, Zulcinski M, Haroon-Rashid L, Kuszlewicz B, et al
    Identification of clonally expanded T-cell receptor sequences in giant cell arteritis.
    J Autoimmun. 2025;151:103372.
    PubMed     Abstract available
    
    
    
92. SCIME NV, Grandi SM, De Vera MA, Dennis CL, et al
    Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study.
    J Autoimmun. 2025;151:103370.
    PubMed     Abstract available
    
    
    
93. HUANG Y, Jee E, Kim M, Liu X, et al
    Familial patterns of alopecia areata: A systematic review and meta-analysis.
    J Autoimmun. 2025;151:103378.
    PubMed     Abstract available
    
    
    January 2025
94. LI J, Xie Z, Yang L, Guo K, et al
    The impact of gut microbiome on immune and metabolic homeostasis in type 1 diabetes: Clinical insights for prevention and treatment strategies.
    J Autoimmun. 2025;151:103371.
    PubMed     Abstract available
    
    
    
95. UPPIN V, Gibbons H, Troje M, Feinberg D, et al
    CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy.
    J Autoimmun. 2025;151:103369.
    PubMed     Abstract available
    
    
    
96. AROWOSEGBE A, Guo Z, Vanderleeden E, Derr AG, et al
    Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats.
    J Autoimmun. 2025;151:103358.
    PubMed     Abstract available
    
    
    
97. LU Y, Man XY
    Diversity and function of regulatory T cells in health and autoimmune diseases.
    J Autoimmun. 2025;151:103357.
    PubMed     Abstract available
    
    
    
98. ANDERSEN SS, Neumann TF, Dannesbo S, Raja AA, et al
    Maternal autoimmune systemic connective tissue disease and vasculitis and electrocardiographic findings in the offspring.
    J Autoimmun. 2025;150:103356.
    PubMed     Abstract available
    
    
    
99. AKUTSU Y, Ota M, Itamiya T, Mori M, et al
    Effect of Epstein-Barr Virus infection on gene regulation in immune cells of patients with Immune-Mediated Diseases.
    J Autoimmun. 2025;150:103355.
    PubMed     Abstract available
    
    
    December 2024
100. ZENG L, Li Y, Xiang W, Xiao W, et al
     Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications.
     J Autoimmun. 2024;150:103350.
     PubMed     Abstract available
     
     
     
101. MAHDY AKH, Lokes E, Schopfel V, Kriukova V, et al
     Bulk T cell repertoire sequencing (TCR-Seq) is a powerful technology for understanding inflammation-mediated diseases.
     J Autoimmun. 2024;149:103337.
     PubMed     Abstract available
     
     
     
102. SORIN B, Papo M, Sinico RA, Teixeira VS, et al
     Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors.
     J Autoimmun. 2024;149:103338.
     PubMed     Abstract available
     
     
     
103. BERTI A, Tomasi M, Pesce I, Lista E, et al
     Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow.
     J Autoimmun. 2024;149:103330.
     PubMed     Abstract available
     
     
     
104. LONG H, Espinosa L, Sawalha AH
     Unraveling the immunomodulatory impact of hydroxychloroquine on peripheral T cells using single-cell RNA sequencing.
     J Autoimmun. 2024;149:103324.
     PubMed     Abstract available
     
     
     
105. EHRSTROM A, Jansson S, Jorgensen MH, Wewer V, et al
     The risk of cancer in pediatric-onset immune-mediated inflammatory diseases - A nationwide study.
     J Autoimmun. 2024;149:103321.
     PubMed     Abstract available
     
     
     
106. PENG X, Wang S, Wu K, Cook C, et al
     Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis.
     J Autoimmun. 2024;149:103307.
     PubMed     Abstract available
     
     
     
107. MAZ MP, Reddy AL, Berthier CC, Tsoi LC, et al
     Lupus-prone NZM2328 mice exhibit enhanced UV-induced myeloid cell recruitment and activation in a type I interferon dependent manner.
     J Autoimmun. 2024;149:103296.
     PubMed     Abstract available
     
     
     November 2024
108. FENG Y, Deyanat-Yazdi G, Newburn K, Potter S, et al
     PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation - therapeutic implications for autoimmunity.
     J Autoimmun. 2024;149:103339.
     PubMed     Abstract available
     
     
     
109. YANG Y, Li M, Ding L, Zhang Y, et al
     EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification.
     J Autoimmun. 2024;149:103341.
     PubMed     Abstract available
     
     
     
110. NOTARNICOLA A, Hellstrom C, Horuluoglu B, Pin E, et al
     Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.
     J Autoimmun. 2024;149:103332.
     PubMed     Abstract available
     
     
     
111. YANGINLAR C, Rother N, Post TGJM, Jacobs M, et al
     Trained innate immunity in response to nuclear antigens in systemic lupus erythematosus.
     J Autoimmun. 2024;149:103335.
     PubMed     Abstract available
     
     
     
112. SU QY, Jiang ZQ, Song XY, Zhang SX, et al
     Regulatory B cells in autoimmune diseases: Insights and therapeutic potential.
     J Autoimmun. 2024;149:103326.
     PubMed     Abstract available
     
     
     
113. HU SZ, Yuan ZY, Zhang XX, Yu XJ, et al
     The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential.
     J Autoimmun. 2024;149:103329.
     PubMed     Abstract available
     
     
     
114. PERURENA-PRIETO J, Sanz-Martinez MT, Vinas-Gimenez L, Codina-Clavaguera C, et al
     Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing.
     J Autoimmun. 2024;149:103328.
     PubMed     Abstract available
     
     
     October 2024
115. KALIN T, Passarin K, Filipowic-Sinnreich M, Semela D, et al
     SARS-CoV-2 mRNA vaccines do not worsen autoimmunity in patients with autoimmune liver diseases.
     J Autoimmun. 2024;149:103325.
     PubMed     Abstract available
     
     
     
116. IIJIMA N, Yamaguchi M, Hayashi T, Rui Y, et al
     miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases.
     J Autoimmun. 2024;149:103319.
     PubMed     Abstract available
     
     
     
117. HASSLER S, Lorenzon R, Binvignat M, Ribet C, et al
     Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases.
     J Autoimmun. 2024;149:103318.
     PubMed     Abstract available
     
     
     September 2024
118. HUA Y, Jiang P, Dai C, Li M, et al
     Extracellular vesicle autoantibodies.
     J Autoimmun. 2024;149:103322.
     PubMed     Abstract available
     
     
     
119. BLANK M, Israeli D, Shoenfeld Y
     Exercise, autoimmune diseases and T-regulatory cells.
     J Autoimmun. 2024;149:103317.
     PubMed     Abstract available
     
     
     
120. PETER B, Rebeaud J, Vigne S, Bressoud V, et al
     Perivascular B cells link intestinal angiogenesis to immunity and to the gut-brain axis during neuroinflammation.
     J Autoimmun. 2024;148:103292.
     PubMed     Abstract available
     
     
     
121. LI C, Liu H, Yang L, Liu R, et al
     Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments.
     J Autoimmun. 2024;148:103286.
     PubMed     Abstract available
     
     
     August 2024
122. ZENG L, Yang K, Wu Y, Yu G, et al
     Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases.
     J Autoimmun. 2024;148:103291.
     PubMed     Abstract available
     
     
     
123. ROJAS M, Acosta-Ampudia Y, Heuer LS, Zang W, et al
     Antigen-specific T cells and autoimmunity.
     J Autoimmun. 2024;148:103303.
     PubMed     Abstract available
     
     
     
124. OAKES EG, Dillon E, Buhler KA, Guan H, et al
     Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
     J Autoimmun. 2024;148:103299.
     PubMed     Abstract available
     
     
     July 2024
125. LIU Q, Jiang Y, Frisell T, Stridh P, et al
     Shared aetiology underlying multiple sclerosis and other immune mediated inflammatory diseases: Swedish familial co-aggregation and large-scale genetic correlation analyses.
     J Autoimmun. 2024;148:103294.
     PubMed     Abstract available
     
     
     
126. ALVAREZ-LOPEZ AI, Alvarez-Sanchez N, Cruz-Chamorro I, Santos-Sanchez G, et al
     Melatonin synergistically potentiates the effect of methylprednisolone on reducing neuroinflammation in the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
     J Autoimmun. 2024;148:103298.
     PubMed     Abstract available
     
     
     
127. BERRYMAN MA, Ilonen J, Triplett EW, Ludvigsson J, et al
     Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease.
     J Autoimmun. 2024;148:103290.
     PubMed     Abstract available
     
     
     
128. BOGERS L, Rip J, Rijvers L, van Langelaar J, et al
     Impact of coding risk variant IFNGR2 on the B cell-intrinsic IFN-gamma signaling pathway in multiple sclerosis.
     J Autoimmun. 2024;148:103279.
     PubMed     Abstract available
     
     
     
129. SOLIGNAC M, Cabrera N, Fouillet-Desjonqueres M, Duquesne A, et al
     JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study.
     J Autoimmun. 2024;147:103248.
     PubMed     Abstract available
     
     
     
130. LEI L, Feng S
     Immune interplay from circulation to local lesion in pemphigus pathogenesis.
     J Autoimmun. 2024;147:103261.
     PubMed     Abstract available
     
     
     
131. MANNING JE, Harris E, Mathieson H, Sorensen L, et al
     Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
     J Autoimmun. 2024;147:103260.
     PubMed     Abstract available
     
     
     June 2024
132. YUAN L, Wang Y, Shen X, Ma F, et al
     Soluble form of immune checkpoints in autoimmune diseases.
     J Autoimmun. 2024;147:103278.
     PubMed     Abstract available
     
     
     
133. TSAY GJ, Zouali M
     Cellular pathways and molecular events that shape autoantibody production in COVID-19.
     J Autoimmun. 2024;147:103276.
     PubMed     Abstract available
     
     
     
134. HU P, Xiao H, Elmore S, Agosto-Burgos C, et al
     Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice.
     J Autoimmun. 2024;147:103266.
     PubMed     Abstract available
     
     
     
135. FAN G, Li G, Li L, Da Y, et al
     Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation.
     J Autoimmun. 2024;147:103262.
     PubMed     Abstract available
     
     
     
136. HANKARD A, Maalouf G, Laouni J, Espitia O, et al
     Outcome and prognosis of isolated carotid vasculitis.
     J Autoimmun. 2024;146:103242.
     PubMed     Abstract available
     
     
     
137. BONASIA CG, Inrueangsri N, Bijma T, Mennega KP, et al
     Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity.
     J Autoimmun. 2024;146:103236.
     PubMed     Abstract available
     
     
     
138. LI Q, Jia C, Pan W, Liu H, et al
     Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients.
     J Autoimmun. 2024;146:103203.
     PubMed     Abstract available
     
     
     May 2024
139. CHOE YH, Jo MG, Kim BG, Lee S, et al
     The autoimmune response induced by alpha-synuclein peptides drives neuronal cell death and glial cell activation.
     J Autoimmun. 2024;147:103256.
     PubMed     Abstract available
     
     
     
140. HEMON M, Giassi M, Ghaffar Y, Martin M, et al
     Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
     J Autoimmun. 2024;146:103238.
     PubMed     Abstract available
     
     
     
141. ESTUPINAN-MORENO E, Hernandez-Rodriguez J, Li T, Ciudad L, et al
     Decoding CD4(+) T cell transcriptome in giant cell arteritis: Novel pathways and altered cross-talk with monocytes.
     J Autoimmun. 2024;146:103240.
     PubMed     Abstract available
     
     
     
142. AKATSU C, Tsuneshige T, Numoto N, Long W, et al
     CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
     J Autoimmun. 2024;146:103245.
     PubMed     Abstract available
     
     
     
143. DAS S, Stamnaes J, Hoydahl LS, Skagen C, et al
     Selective activation of naive B cells with unique epitope specificity shapes autoantibody formation in celiac disease.
     J Autoimmun. 2024;146:103241.
     PubMed     Abstract available
     
     
     
144. YANG Y, Jiang H, Tang Z, Pan H, et al
     Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice.
     J Autoimmun. 2024;146:103237.
     PubMed     Abstract available
     
     
     
145. ZOU X, Huo F, Sun L, Huang J, et al
     Peripheral helper T cells in human diseases.
     J Autoimmun. 2024;145:103218.
     PubMed     Abstract available
     
     
     
146. WANG K, Hou X, Lu H, Han N, et al
     Ectopic CD4(+) T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-gamma induced microglia activation.
     J Autoimmun. 2024;145:103199.
     PubMed     Abstract available
     
     
     
147. LIN M, Huang L, Huang J, Yu J, et al
     Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice.
     J Autoimmun. 2024;145:103198.
     PubMed     Abstract available
     
     
     April 2024
148. HUANG B, Li H, Jiang Q, Li Y, et al
     Elevated type I IFN signalling directly affects CD8(+) T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients.
     J Autoimmun. 2024;146:103232.
     PubMed     Abstract available
     
     
     
149. LI J, Cheng C, Zhang J
     Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis.
     J Autoimmun. 2024;146:103231.
     PubMed     Abstract available
     
     
     
150. ESEN I, Sandovici M, Heeringa P, Boots AMH, et al
     Impaired IL-6-induced JAK-STAT signaling in CD4(+) T cells associates with longer treatment duration in giant cell arteritis.
     J Autoimmun. 2024;146:103215.
     PubMed     Abstract available
     
     
     
151. CHUANG HC, Lan KY, Hsu PM, Chen MH, et al
     UHRF1P contributes to IL-17A-mediated systemic lupus erythematosus via UHRF1-MAP4K3 axis.
     J Autoimmun. 2024;146:103221.
     PubMed     Abstract available
     
     
     
152. DO JS, Arribas-Layton D, Juan J, Garcia I, et al
     The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
     J Autoimmun. 2024;146:103228.
     PubMed     Abstract available
     
     
     
153. WORZNER K, Zimmermann J, Buhl R, Desoi A, et al
     Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype.
     J Autoimmun. 2024;144:103174.
     PubMed     Abstract available
     
     
     
154. STUCCHI A, Maspes F, Montee-Rodrigues E, Fousteri G, et al
     Engineered Treg cells: The heir to the throne of immunotherapy.
     J Autoimmun. 2024;144:102986.
     PubMed     Abstract available
     
     
     March 2024
155. DZIEDZIC A, Michlewska S, Jozwiak P, Debski J, et al
     Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).
     J Autoimmun. 2024;145:103204.
     PubMed     Abstract available
     
     
     
156. WANG Y, Wang S, Liu W, Gu H, et al
     Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice.
     J Autoimmun. 2024;145:103205.
     PubMed     Abstract available
     
     
     
157. HUANG W, Jin T, Zheng W, Yin Q, et al
     Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
     J Autoimmun. 2024;145:103188.
     PubMed     Abstract available
     
     
     
158. GARCIA-LOZA I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, et al
     Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
     J Autoimmun. 2024;145:103196.
     PubMed     Abstract available
     
     
     
159. CHAVULA T, To S, Smith J, Pedroza M, et al
     CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.
     J Autoimmun. 2024;145:103197.
     PubMed     Abstract available
     
     
     February 2024
160. BONACINI M, Rossi A, Ferrigno I, Muratore F, et al
     miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.
     J Autoimmun. 2024;144:103186.
     PubMed     Abstract available
     
     
     
161. FISCHER S, Meisinger C, Freuer D
     Autoimmune diseases and female-specific cancer risk: A systematic review and meta-analysis.
     J Autoimmun. 2024;144:103187.
     PubMed     Abstract available
     
     
     
162. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
     The enigma of sclera-specific autoimmunity in scleritis.
     J Autoimmun. 2024;144:103178.
     PubMed     Abstract available
     
     
     
163. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
     Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
     J Autoimmun. 2024;144:103180.
     PubMed     Abstract available
     
     
     
164. NEYS SFH, Heutz JW, van Hulst JAC, Vink M, et al
     Aberrant B cell receptor signaling in circulating naive and IgA(+) memory B cells from newly-diagnosed autoantibody-positive rheumatoid arthritis patients.
     J Autoimmun. 2024;143:103168.
     PubMed     Abstract available
     
     
     
165. LORENZON R, Ribet C, Pitoiset F, Aractingi S, et al
     The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
     J Autoimmun. 2024;144:103172.
     PubMed     Abstract available
     
     
     
166. TAIEB D, Moyon Q, Lhote R, Annesi-Maesano I, et al
     Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
     J Autoimmun. 2024;144:103173.
     PubMed     Abstract available
     
     
     January 2024
167. ZHONG T, Li X, Lei K, Tang R, et al
     CXCL12-CXCR4 mediates CD57(+) CD8(+) T cell responses in the progression of type 1 diabetes.
     J Autoimmun. 2024;143:103171.
     PubMed     Abstract available
     
     
     
168. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
     Older age of celiac disease diagnosis and risk of autoimmune disease: A nationwide matched case-control study.
     J Autoimmun. 2024;143:103170.
     PubMed     Abstract available
     
     
     
169. LINDELOF L, Rantapaa-Dahlqvist S, Lundtoft C, Sandling JK, et al
     A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile.
     J Autoimmun. 2024;143:103166.
     PubMed     Abstract available
     
     
     
170. LI Y, Tang C, Vanarsa K, Thai N, et al
     Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
     J Autoimmun. 2024;143:103165.
     PubMed     Abstract available
     
     
     
171. REUSCHLE Q, Van Heddegem L, Bosteels V, Moncan M, et al
     Loss of function of XBP1 splicing activity of IRE1alpha favors B cell tolerance breakdown.
     J Autoimmun. 2024;142:103152.
     PubMed     Abstract available
     
     
     
172. LIBERATORE J, Nguyen Y, Hadjadj J, Cohen P, et al
     Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study.
     J Autoimmun. 2024;142:103130.
     PubMed     Abstract available
     
     
     
173. KELLY S, Jackson KJ, Peters TJ, Suan D, et al
     Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences.
     J Autoimmun. 2024;142:103129.
     PubMed     Abstract available
     
     
     
174. REYNOLDS JA, Li Y, Herlitz L, Mohan C, et al
     Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum.
     J Autoimmun. 2024;142:103134.
     PubMed     Abstract available
     
     
     
175. XU C, Zhang T, Wang H, Zhu L, et al
     Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus.
     J Autoimmun. 2024;142:103128.
     PubMed     Abstract available
     
     
     
176. MERINO-VICO A, van Hamburg JP, Tuijnenburg P, Frazzei G, et al
     Targeting NF-kappaB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.
     J Autoimmun. 2024;142:103133.
     PubMed     Abstract available
     
     
     December 2023
177. PENG X, Li H, Zhu L, Zhao S, et al
     Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.
     J Autoimmun. 2023;143:103160.
     PubMed     Abstract available
     
     
     
178. GAO L, Zhang W, Zhang L, Gromova B, et al
     Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.
     J Autoimmun. 2023;143:103162.
     PubMed     Abstract available
     
     
     
179. BENDER C, Muller P, Tondello C, Horn J, et al
     Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
     J Autoimmun. 2023;143:103161.
     PubMed     Abstract available
     
     
     
180. SOMERS EC, Goodrich JM, Wang L, Harlow SD, et al
     Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program.
     J Autoimmun. 2023;142:103137.
     PubMed     Abstract available
     
     
     
181. SHAO T, Hsu R, Rafizadeh DL, Wang L, et al
     The gut ecosystem and immune tolerance.
     J Autoimmun. 2023;141:103114.
     PubMed     Abstract available
     
     
     
182. GUO Z, Yiu N, Hu Z, Zhou W, et al
     Alterations of fecal microbiome and metabolome in pemphigus patients.
     J Autoimmun. 2023;141:103108.
     PubMed     Abstract available
     
     
     November 2023
183. GREIGERT H, Ramon A, Genet C, Cladiere C, et al
     Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
     J Autoimmun. 2023;142:103151.
     PubMed     Abstract available
     
     
     
184. YASUDA K, Shimodan S, Maehara N, Hirota A, et al
     AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
     J Autoimmun. 2023;142:103149.
     PubMed     Abstract available
     
     
     
185. CARMONA EG, Callejas-Rubio JL, Raya E, Rios-Fernandez R, et al
     Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4(+) T cells in giant cell arteritis.
     J Autoimmun. 2023;142:103124.
     PubMed     Abstract available
     
     
     
186. LABERE B, Nguyen AA, Habiballah SB, Elkins M, et al
     Clinical utility of measuring CD4(+) T follicular cells in patients with immune dysregulation.
     J Autoimmun. 2023;140:103088.
     PubMed     Abstract available
     
     
     October 2023
187. KISHIMOTO TK, Fournier M, Michaud A, Rizzo G, et al
     Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
     J Autoimmun. 2023;140:103125.
     PubMed     Abstract available
     
     
     
188. LI Y, Song H, Meng X, Li R, et al
     Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review.
     J Autoimmun. 2023;140:103121.
     PubMed     Abstract available
     
     
     
189. ERDEI E, O'Donald ER, Luo L, Enright K, et al
     Comparison of circulating and excreted metals and of autoimmunity between two Great Plains Tribal communities.
     J Autoimmun. 2023 Oct 7:103117. doi: 10.1016/j.jaut.2023.103117.
     PubMed     Abstract available
     
     
     
190. DU Y, Brodeur KE, Hsu E, Chen L, et al
     In cis "benign" SOCS1 variants linked to enhanced interferon signaling and autoimmunity.
     J Autoimmun. 2023;140:103119.
     PubMed     Abstract available
     
     
     September 2023
191. MISTRY S, Gouripeddi R, Facelli JC
     Prioritization of infectious epitopes for translational investigation in type 1 diabetes etiology.
     J Autoimmun. 2023;140:103115.
     PubMed     Abstract available
     
     
     
192. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
     Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469].
     J Autoimmun. 2023 Sep 23:103116. doi: 10.1016/j.jaut.2023.103116.
     PubMed    
     
     
     
193. WINANS T, Oaks Z, Choudhary G, Patel A, et al
     mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
     J Autoimmun. 2023;140:103112.
     PubMed     Abstract available
     
     
     
194. TERZIROLI BERETTA-PICCOLI B, Buescher G, Dalekos G, Zachou K, et al
     Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
     J Autoimmun. 2023;140:103113.
     PubMed     Abstract available
     
     
     
195. LIN Y, Sakuraba S, Massilamany C, Reddy J, et al
     Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
     J Autoimmun. 2023;140:103094.
     PubMed     Abstract available
     
     
     
196. GRAVER JC, Jiemy WF, Altulea DHA, van Sleen Y, et al
     Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
     J Autoimmun. 2023;140:103111.
     PubMed     Abstract available
     
     
     
197. LIU X, Liu M, Zhao M, Li P, et al
     Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges.
     J Autoimmun. 2023 Sep 8:103109. doi: 10.1016/j.jaut.2023.103109.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum